2024-11-20 07:10:28
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease
Corporate/ 2023-07-23
I-Mab Announces IND Approval by FDA to I...

Planning underway for a Phase 1 Trial to assess new immunotherapy aimed at stimulating the innate immune system to clear beta amyloid protei...

Appendix 4C - Q4 FY21 Quarterly Cash Flow Report
Corporate/ 2023-07-23
Appendix 4C - Q4 FY21 Quarterly Cash Flo...

Highlights: Positive Guidance from European Medicines Agency for ATH434 Phase 2 Clinical Trial Publication in Movement Disorders demonstrate...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release